Cardiologia

Diretriz científica AHA | Tratamento abrangente dos fatores de risco cardiovascular para adultos com diabetes tipo 2.

12 Jan, 2022 | 12:56h

Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association – Circulation

Comunicado de imprensa: Fewer than 1 in 5 adults with Type 2 diabetes in the U.S. are meeting optimal heart health targets – American Heart Association

---

Pela primeira vez, cirurgiões norte-americanos transplantam um coração de porco para um paciente humano.

12 Jan, 2022 | 12:49h

In 1st, US surgeons transplant pig heart into human patient – Associated Press

---

Revisão | Novos aspectos no tratamento da hipertensão em pacientes com doença renal crônica que não estão em terapia de substituição renal.

12 Jan, 2022 | 12:39h

New Aspects in the Management of Hypertension in Patients with Chronic Kidney Disease not on Renal Replacement Therapy – High Blood Pressure & Cardiovascular Prevention

Conteúdo relacionado: RCT: In patients with advanced chronic kidney disease and poorly controlled hypertension, Chlortalidone had a significant impact in blood-pressure control (−11.0 mm Hg vs. −0.5 mm Hg in the placebo group).

---

Os “10 mandamentos” das Diretrizes ESC 2021 para diagnóstico e tratamento das insuficiências cardíacas aguda e crônica.

12 Jan, 2022 | 12:38h

The ‘Ten Commandments’ of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure – European Heart Journal

Diretriz original: #ESCCongress – 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure – SGLT2 inhibitors are now recommended for patients with heart failure with reduced ejection fraction regardless of the presence of diabetes.

Conteúdos relacionados:

NICE Guideline | Acute heart failure: diagnosis and management.

The ‘ten commandments’ for the 2021 ESC Guidelines on CVD prevention.

---

Estudo de registro | Determinantes dos desfechos após cirurgia de dissecção aórtica aguda tipo A.

12 Jan, 2022 | 12:28h

Determinants of outcomes following surgery for type A acute aortic dissection: the UK National Adult Cardiac Surgical Audit – European Heart Journal

Editorial: Acute type A aortic dissection reconsidered: it’s all about the location of the primary entry tear and the presence or absence of malperfusion

 

Comentário no Twitter

Determinants of outcomes following surgery for type A acute aortic dissection: the UK National Adult Cardiac Surgical Audit https://t.co/nKH9jJLjdp #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/5C5jGd4DV6

— European Society of Cardiology Journals (@ESC_Journals) September 30, 2021

 

---

[Preprint] Risco de miocardite após vacinações sequenciais contra COVID-19 por idade e sexo.

10 Jan, 2022 | 12:43h

Risk of myocarditis following sequential COVID-19 vaccinations by age and sex – medRxiv

Comentário: An evaluation of the association between COVID vaccination and myocarditis in 42 million people aged 13 or older – News Medical

Nota: este estudo é uma análise atualizada de um estudo recente, publicado na revista Nature Medicine; ver abaixo:

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination vs. SARS-CoV-2 infection.

---

Diretriz Científica AHA | Hipertensão na gestação: diagnóstico, metas de pressão arterial e farmacoterapia.

10 Jan, 2022 | 12:23h

Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association – Hypertension

Comunicado de imprensa: High blood pressure treatment in pregnancy is safe, prevents maternal heart risks – American Heart Association

 

Comentário no Twitter

Have you had a chance to check out the new Scientific Statement From the American Heart Association?!?

Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Associationhttps://t.co/hs6zPwOP2N pic.twitter.com/CUs1jxCP5M

— Hypertension (@HyperAHA) December 20, 2021

 

---

AHA aponta os principais avanços em doença cardíaca e AVC de 2021.

10 Jan, 2022 | 12:21h

AHA names top heart disease and stroke research advances of 2021 – American Heart Association

---

Em um amplo estudo de coorte retrospectivo que analisou pacientes de 65 anos de idade ou mais com fibrilação atrial, o tratamento com rivaroxabam comparado com apixabam foi associado com risco aumentado de eventos isquêmicos ou hemorrágicos maiores.

10 Jan, 2022 | 11:49h

Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation – JAMA

Comentário: Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study – TCTMD

Conteúdo relacionado:

Meta-Analysis Comparing Apixaban Versus Rivaroxaban for Management of Patients With Nonvalvular Atrial Fibrillation – American Journal of Medicine

Observational Study Suggests Apixaban May Be a Better Choice than Rivaroxaban for Patients with Atrial Fibrillation

---

Estudo de coorte retrospectivo | Em pacientes com tromboembolismo venoso (TEV), o tratamento com apixabam foi associado com menores taxas de TVE recorrente e sangramento em comparação ao rivaroxabam.

10 Jan, 2022 | 11:47h

Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data – Annals of Internal Medicine

Comentários:

Apixaban shows superior effectiveness, safety compared to rivaroxaban – ACP Internist

Recurrent VTE and Bleeding With Apixaban vs. Rivaroxaban – American College of Cardiology

---